We further validated the association of ATRIP deleterious mutations with an increased risk of breast cancer using WES data of 15,643 Caucasian breast cancer patients and 157,943 ethnically matched cancer-free individuals from the UK Biobank (UKB) cohort study. Here, ATRIP is linked to breast cancer.